These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

759 related articles for article (PubMed ID: 25453266)

  • 1. Clinical implications of miRNAs in the pathogenesis, diagnosis and therapy of pancreatic cancer.
    Rachagani S; Macha MA; Heimann N; Seshacharyulu P; Haridas D; Chugh S; Batra SK
    Adv Drug Deliv Rev; 2015 Jan; 81():16-33. PubMed ID: 25453266
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insights into the Role of microRNAs in Pancreatic Cancer Pathogenesis: Potential for Diagnosis, Prognosis, and Therapy.
    Khan MA; Zubair H; Srivastava SK; Singh S; Singh AP
    Adv Exp Med Biol; 2015; 889():71-87. PubMed ID: 26658997
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aberrant microRNAs expression patterns in pancreatic cancer and their clinical translation.
    Du Y; Liu M; Gao J; Li Z
    Cancer Biother Radiopharm; 2013 Jun; 28(5):361-9. PubMed ID: 23621126
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Emerging roles of microRNAs in pancreatic cancer diagnosis, therapy and prognosis (Review).
    Subramani R; Gangwani L; Nandy SB; Arumugam A; Chattopadhyay M; Lakshmanaswamy R
    Int J Oncol; 2015 Oct; 47(4):1203-10. PubMed ID: 26314882
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA in pancreatic adenocarcinoma: predictive/prognostic biomarkers or therapeutic targets?
    Brunetti O; Russo A; Scarpa A; Santini D; Reni M; Bittoni A; Azzariti A; Aprile G; Delcuratolo S; Signorile M; Gnoni A; Palermo L; Lorusso V; Cascinu S; Silvestris N
    Oncotarget; 2015 Sep; 6(27):23323-41. PubMed ID: 26259238
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Investigating the regulatory role of miRNAs as silent conductors in the management of pathogenesis and therapeutic resistance of pancreatic cancer.
    Abulsoud AI; Elshaer SS; Abdelmaksoud NM; Zaki MB; El-Mahdy HA; Ismail A; Al-Noshokaty TM; Fathi D; Abdel-Reheim MA; Mohammed OA; Doghish AS
    Pathol Res Pract; 2023 Nov; 251():154855. PubMed ID: 37806169
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNAs as biomarkers and perspectives in the therapy of pancreatic cancer.
    Xia T; Chen XY; Zhang YN
    Mol Cell Biochem; 2021 Dec; 476(12):4191-4203. PubMed ID: 34324119
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Developments in miRNA gene signaling pathways in pancreatic cancer.
    Vorvis C; Koutsioumpa M; Iliopoulos D
    Future Oncol; 2016 May; 12(9):1135-50. PubMed ID: 26984178
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA regulation of K-Ras in pancreatic cancer and opportunities for therapeutic intervention.
    Karmakar S; Kaushik G; Nimmakayala R; Rachagani S; Ponnusamy MP; Batra SK
    Semin Cancer Biol; 2019 Feb; 54():63-71. PubMed ID: 29199014
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dysregulation of key microRNAs in pancreatic cancer development.
    Baradaran B; Shahbazi R; Khordadmehr M
    Biomed Pharmacother; 2019 Jan; 109():1008-1015. PubMed ID: 30551350
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circulating microRNAs as Potential Biomarkers in Pancreatic Cancer-Advances and Challenges.
    Seyhan AA
    Int J Mol Sci; 2023 Aug; 24(17):. PubMed ID: 37686149
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA in Pancreatic Cancer: From Biology to Therapeutic Potential.
    Rawat M; Kadian K; Gupta Y; Kumar A; Chain PSG; Kovbasnjuk O; Kumar S; Parasher G
    Genes (Basel); 2019 Sep; 10(10):. PubMed ID: 31557962
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNAs in Pancreatic Cancer: biomarkers, prognostic, and therapeutic modulators.
    Daoud AZ; Mulholland EJ; Cole G; McCarthy HO
    BMC Cancer; 2019 Nov; 19(1):1130. PubMed ID: 31752758
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular Drivers of Pancreatic Cancer Pathogenesis: Looking Inward to Move Forward.
    Khan MA; Azim S; Zubair H; Bhardwaj A; Patel GK; Khushman M; Singh S; Singh AP
    Int J Mol Sci; 2017 Apr; 18(4):. PubMed ID: 28383487
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Noncoding RNAs and pancreatic cancer.
    Peng JF; Zhuang YY; Huang FT; Zhang SN
    World J Gastroenterol; 2016 Jan; 22(2):801-14. PubMed ID: 26811626
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA in pancreatic cancer: pathological, diagnostic and therapeutic implications.
    Rachagani S; Kumar S; Batra SK
    Cancer Lett; 2010 Jun; 292(1):8-16. PubMed ID: 20004512
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Diagnosis, treatment and prognosis evaluation of pancreatic cancer by microRNA].
    Ren H; Wang CF
    Zhonghua Zhong Liu Za Zhi; 2020 Nov; 42(11):903-906. PubMed ID: 33256299
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of miRNAs in gastrointestinal cancer diagnosis and prognosis.
    Song B; Ju J
    Expert Rev Mol Med; 2010 Oct; 12():e33. PubMed ID: 20942990
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNAs as potential therapeutic targets for pancreatic cancer.
    Chu X; Wei D; Liu X; Long D; Tian X; Yang Y
    Chin Med J (Engl); 2022 Jan; 135(1):4-10. PubMed ID: 34839317
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical Value of Circulating miRNA in Diagnosis, Prognosis, Screening and Monitoring Therapy of Pancreatic Ductal Adenocarcinoma-A Review of the Literature.
    Wnuk J; Strzelczyk JK; Gisterek I
    Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982210
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 38.